Anti-obesity drug market on steady growth path in India

 

 With around 70 million obese people, the market for antiobesity drugs in India is growing steadily. One in four Indians is overweight, shows data from the National Family  MAT* (in $cr)  Health Survey (NFHS) 2022.

Post a Comment

0 Comments